NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,981 | +227.0% | 53,952 | +235.8% | 0.00% | – |
| Q4 2022 | $3,052 | -49.1% | 16,067 | -0.2% | 0.00% | – |
| Q3 2022 | $6,000 | -64.7% | 16,103 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -45.2% | 16,103 | 0.0% | 0.00% | – |
| Q1 2022 | $31,000 | -34.0% | 16,103 | -2.2% | 0.00% | – |
| Q4 2021 | $47,000 | -35.6% | 16,462 | -18.6% | 0.00% | – |
| Q3 2021 | $73,000 | -51.3% | 20,236 | -35.4% | 0.00% | – |
| Q2 2021 | $150,000 | -32.7% | 31,312 | +3.7% | 0.00% | – |
| Q1 2021 | $223,000 | +41.1% | 30,194 | +34.1% | 0.00% | – |
| Q4 2020 | $158,000 | +3.3% | 22,511 | +11.1% | 0.00% | – |
| Q3 2020 | $153,000 | -37.6% | 20,268 | -27.4% | 0.00% | – |
| Q2 2020 | $245,000 | +276.9% | 27,913 | +206.2% | 0.00% | – |
| Q1 2020 | $65,000 | +6400.0% | 9,115 | +5936.4% | 0.00% | – |
| Q3 2019 | $1,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |